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Egyptian childrenAbstract Background: Classical autism belongs to a group of heterogeneous neurobehavioral dis-
orders known as autism spectrum disorders (ASDs) characterized by abnormalities in social inter-
action, impaired communication, and repetitive stereotypic behaviors. Overall, there is an increased
risk of ASDs associated with common mutations affecting the folate/methylation cycle. This study
aimed at identiﬁcation of the C677T polymorphic genotypes of MTHFR gene among the Egyptian
children with autism and to correlate them with different phenotypes.
Subjects and methods: This case-control study included 20 children with autism
(4.57 ± 1.36 years) (13 males and 7 females) and a normal control group. Assessments by DSM-
IV-TR criteria, Stanford-Binet intelligence scale and childhood autism rating scale (CARS) were
done. Assay for MTHFR gene mutation C677T was performed on ampliﬁed DNA by PCR and
subsequent reverse hybridization to immobilized allele-speciﬁc biotinylated oligonucleotides probes.
Results: The relation between low birth weight and occurrence of autism is highly signiﬁcant
(P< 0.01). The delayed motor and social milestones showed a statistically highly signiﬁcant differ-
ence in cases of autism compared to controls (P< 0.01); 50% of autistic patients were heterozygous
(CT) for the MTHFR gene, and 15% were homozygotes for the mutant genotype (TT). For the
homozygous wild type genotype, 35% of patients were CC (P< 0.05). The segregation of T allele
in the homozygous 677TT genotype occurred in 30% of autistic children. Frequency of the T-allele
in autistic children is 0.4 compared to an allele frequency of 0.3 among controls (P< 0.01). Accord-
ing to the CARS classiﬁcation, 70% were severely affected of whom 42.8% were carrying the CT
336 R.M. Shawky et al.genotype. There was no signiﬁcant difference between CARS (degree of severity of autism) and
C677T polymorphism. There was no signiﬁcant difference between various genotypes as regards
the mean for CARS. There was no statistically signiﬁcant difference as regards mean gestational
age, birth weight and mean age at sitting down among the patient group with different genotypes
(P> 0.05).
Conclusion: Although the 677CT variant alleles signiﬁcantly increased in patients with autism, it
is unlikely that this association alone is sufﬁcient to produce the complex array of symptoms asso-
ciated with autism. Therefore, a search for additional genomic, metabolic, epigenetic and environ-
mental risk factors should be undertaken.
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Autism is a complex neuro developmental disorder that is
increasingly being recognized as a public health issue [1]. It is
currently estimated that 3–6 children out of every 1000 world-
wide have autism spectrum disorders (ASDs) [2], with three to
four fold higher incidence in males than in females [3]. In the
year 2014, the Centers for Disease Control and Prevention
(CDC) released new data on the prevalence of autism in the
United States. This surveillance study identiﬁed 1 in 68 chil-
dren (1 in 42 boys and 1 in 189 girls) as having autism spec-
trum disorder (ASD) [4]. It is classiﬁed under the pervasive
developmental disorders (PDDs) that involve a combination
of impairments in communication, reciprocal social interac-
tions, and stereotyped patterns of interest/behavior. PDDs
include autism (classical autism which is considered the most
severe form of ASD); Asperger’s syndrome (which generally
preserves an individual’s linguistic development); childhood
disintegrative disorder, and PDD – not otherwise speciﬁed
(PDD–NOS) [5,6]. Autism spectrum disorders are character-
ized by language impairment, restricted interests, stereotypic
motor behaviors, hyperactivity, sensory disturbances and self
injury [7]. It is also associated with seizure disorder [8], gastro-
intestinal disturbances [9] and autoimmune disorders in some
patients [10].
The methylene tetrahydrofolate reductase (MTHFR) gene
codes for an essential enzyme in folate metabolism. There is
an evidence of increased risk of autism spectrum disorders
(ASDs) associated with common mutations affecting the
folate/methylation cycle. These associations by themselves
may provide a partial explanation for a subgroup of chil-
dren genomically at – risk for ASDs. Increased folinic acid
during pregnancy and early development may offset the
genomic risk factors. Since folate-dependent methylation
provides, in part, the methyl group for inactivation of
monoamine neurotransmitters via the Catecholamine –O–
Methyltransferase (COMT) system, this observation may
help to further differentiate subtypes within the broad phe-
notypes of ASDs [11].
The present study aimed at identiﬁcation of the C677T gene
mutation in the MTHFR gene among the Egyptian sample of
patients with autism and to correlate the detected polymorphic
genotypes with different phenotypes among the children
involved in the study.2. Patients and methods
2.1. Patients
This case control study enrolled 20 child patients with autism
diagnosed by DSM-IV-TR criteria [12]. Patients were recruited
from the Psychiatric Clinic, Pediatric Hospital, Ain Shams
University. They were 13 males (65%) and 7 females (35%).
Their ages ranged from 3 to 7 years (mean age
4.57 ± 1.36 years). The control group included 20 healthy chil-
dren [13 males (65%) and 7 females (35%)]. Their ages ranged
from 3 to 8 years (mean 4.9 ± 1.58 years). The control chil-
dren were referred to the psychiatric clinic to exclude the pres-
ence of autism spectrum disorders (ASDs). All of the patients
were subjected to the following:
Detailed history taking was done with special emphasis on
the onset, course and duration of the disease, consanguinity of
the parents; antenatal history with special emphasis on history
of threatened abortion, any fetal loss, parity and chronic
illness. Natal and postnatal histories including gestational
age, complications during labor, history of prematurity or
intrauterine growth retardation, birth weight; perinatal prob-
lems and postnatal course especially the occurrence of neona-
tal hypoxia, resuscitation, pallor and jaundice. The
developmental history included age of sitting without support,
walking unassisted, ﬁrst spoken word, combining words, accu-
rate details of cognitive abilities, gross and ﬁne motor func-
tions, feeding disorders, abnormal sleep patterns and history
of vaccination. In addition, family history was taken for any
similar conditions, genetic diseases and other psychological
or mental disorders in the family. Thorough clinical examina-
tion with laying stress on neurological examination was done.2.2. Methods
- Conﬁrmation of diagnosis was performed using a DSM-IV-
TR criteria questionnaire of autism, i.e. impairments of lan-
guage, social skills, and restricted stereotyped interest or
activity [12].
- Assessment of mental age using the Stanford-Binet intelli-
gence scale (2003) [13] to calculate the intelligence quotient
(IQ). Subnormal intellectual function is diagnosed when IQ
is below 70.
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hood autism rating scale (CARS) [14] which rates the child
on a scale from one to four in each of ﬁfteen areas (relating
to people, emotional response, imitation, body use, object
use, listening response, fear or nervousness, verbal commu-
nication, non-verbal communication, activity level, and
consistency of intellectual response, adaptation to change,
visual response, taste, smell, touch response and general
impression) was done.
- Assay for the detection of methylene tetrahydrofolate
reductase (MTHFR) gene mutation C677T was performed
based on polymerase chain reaction (PCR) ampliﬁcation of
the DNA and subsequent reverse hybridization to immobi-
lized allele-speciﬁc biotinylated oligonucleotide probes
(Vienna lab diagnostics GmbH, Vienna, Austria). DNA
isolation was obtained from peripheral blood samples using
the spin column method and GENX TRACT Resin of
Vienna lab diagnostics. In Vitro ampliﬁcation (PCR)
was performed on 5–40 lg/ml DNA template. The PCR
protocol was performed on a thermal cycler HVD as fol-
lows: Pre-PCR 94 C/2 min. Thermocycling for 30 cycles
each consists of 94 C/15 s, 58 C/30 s and 72 C/30 s. Final
extension at 72 C/3 min. Analysis of the ampliﬁed prod-
ucts on 3% agarose gel electrophoresis to detect a 202 bp
fragment was done. Hybridization of the ampliﬁed PCR
products was conjugated using the streptavidin–alkaline
phosphatase solution with subsequent serial washing using
0.05% NaN3-containing solution. Detection of the hybrid-
ized PCR products was done using nitro blue tetrazolium
(NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP)
solution.
- MTHFR gene C677T polymorphism was interpreted as a
homozygote mutant, heterozygote or normal wild type
genotypes.
- Statistical analysis: The results were analyzed using the Sta-
tistical Package of Social Sciences (SPSS) computer soft-
ware program, version 11.0 (Chicago, IL, USA).
Quantitative data were presented as mean ± SD for nor-
mally distributed data and as medians and percentiles for
skewed data. Qualitative data were presented in the form
of frequencies and percentages. For normally distributed
parameters, differences among groups were tested by the t
test and a one-way analysis of variance (ANOVA). For
Qualitative data, differences among groups were tested
using Pearson’s chi-square test (X2). A P value less than
0.05 was considered statistically signiﬁcant.
Informed consent was taken from parents of the infants.
3. Results
Among the patient group, consanguinity was detected in 20%
of patients compared to 15% in the control group. In the
patient group, 10% have similar autistic patients in the family;
15% have a history of epilepsy in the family, 10% of the
patients have a history of prematurity .Thirteen (65%) were
breast fed and seven (35%) were artiﬁcially fed. The mean
for gestational age in our patients was 39 ± 25 weeks while
in the control the mean gestational age was 39.1 ± 0.5 weeks
.The mean for birth weight in our patients was
2.67 ± 0.389 kg compared to 3.03 ± 0.309 kg in the controlgroup .The relation between gestational age and occurrence
of autism was not signiﬁcant statistically (P> 0.05) while
the relation of low birth weight to autism was highly signiﬁcant
(P< 0.01). In our patients, the mean age for sitting was
8.5 ± 1.1 months while in the control group it was
6.65 ± 0.87 months. Mean age for the ﬁrst spoken word in
our patients was 2.6 ± 0.69 years while in the control group
it was 1.13 ± 0.18 years. These delayed motor and develop-
mental milestones showed statistically highly signiﬁcant differ-
ence in patients of autism compared to controls. Among our
patient group, 18 had IQ scores ranging from 35 to 65 with
a mean of 54 ± 14.7 while the control group had normal IQ
ranging from 95 to 115 with a mean of 96 ± 8.9. The IQ
was signiﬁcantly lower in autistic patients than in controls
(P< 0.01) (Table 1).
In the present study, 10 patients (50%) were heterozygous
(CT) for the MTHFR gene compared to only 6 in the control
group (30%). However this difference was not signiﬁcant
(P> 0.05). The homozygote mutant genotype TT was
detected in 3 patients (15%) compared to 0% in the control
group (P> 0.05). For the homozygous wild genotype, 7
patients (35%) had the CC genotype compared to 14 (70%)
of the control group. This was statistically signiﬁcant
(P< 0.05) (Table 2).
The segregation of the T allele in the homozygous 677TT
genotype occurred in 3 patients (15%) among the autistic chil-
dren, while in the heterozygous 677CT genotype it occurred in
10 (50%) of the autistic group children. Frequency of the T-
allele in autistic children is 0.4 compared to an allele frequency
of 0.3 among controls (P< 0. 0 1) (Tables 2 and 3).
Two of the autistic patients of the study (10%) had normal
IQ, while ten of them (50%) had mild mental retardation and
six patients (30%) had moderate mental retardation and two
patients (10%) had severe retardation with no statistically sig-
niﬁcant difference among different genotypes. In this study,
according to the CARS classiﬁcation there were no mild cases,
while there were 6 patients (30%) with moderate affection; 4
(66.7%) of whom were heterozygous for C667T, and the
majority (14) (70%) of patients were severely affected of whom
6 patients (42.8%) were carrying the CT genotype and also 6
patients (42.8%) were CC in genotype. This indicates that
there was no signiﬁcant difference between CARS (degree of
severity of autism) and C677T polymorphism (P> 0.05). In
the patients of the study, mean IQ score of the heterozygous
group (CT) was 50.8 ± 13.67, mean IQ score of the group with
mutant genotype (TT) was 58.66 ± 5.5, and mean IQ score of
normal genotype (CC) was 57 ± 18.94. Mean CARS of the
heterozygous group was 36.3 ± 5.01, mean CARS of the
group with mutant genotypes was 37.3 ± 4.61 and mean
CARS of the group with normal genotypes was 37.1 ± 3.98
with no signiﬁcant difference (Table 4).
There was no statistically signiﬁcant difference as regards
mean gestational age, birth weight and mean age at sitting
among the patient groups with different genotypes
(P> 0.05) (Table 5).
4. Discussion
There is an agreement that autism is one of the most puzzling
diseases. It is a neuro developmental disorder characterized by
impaired social interaction [15], which is usually diagnosed
Table 1 Characteristics of the patient and control groups included in the study.
Parameters Patients Controls Chi-square test P-value
Consanguinity (no., %)
Yes 4 (20%) 3 (15%) 0.173 >0.05**
No 16 (80%) 17 (85%)
Family history of autism (no., %)
Yes 2 (10%) 0 (0%) 0.529 >0.05**
No 18 (90%) 20 (100%)
Family history of epilepsy (no., %)
Yes 3 (15%) 0 (0%) 1.44 >0.05**
No 17 (85%) 20 (100%)
History of prematurity:
Yes 2 (10%) 0 (0%) 0.526 >0.05**
No 18 (90%) 20(100%)
Feeding
Breast 13 (65%) 16 (80%) 1.129 >0.05**
Artiﬁcial 7 (35%) 4 (20%)
Mean gestational age (weeks) 39 ± 1.25 39.1 ± 0.5 1.48 >0.05**
Mean birth weight (kg) 2.67 ± 0.389 3.03 ± 0.309 3.2 <0.01*
Mean age for sitting (month) 8.5 ± 1.1 6.65 ± 0.87 5.88 <0.01*
Mean age at weaning (year) 1.59 ± 0.3 1.61 ± 0.31 0.206 >0.05**
Mean age at 1st spoken word (year) 2.6 ± 0.69 1.13 ± 0.18 6.63 <0.01*
Mean level of IQ score 54 ± 14.7 96 ± 8.8 11.003 <0.01*
* Highly signiﬁcant difference.
** Non-signiﬁcant difference.
Table 2 Genotypes of MTHFR among the patient and control groups.
Genotype Patients Control Chi square test P-value
No. % No. %
Heterozygous(CT) 10 50 6 30 0.33 >0.05**
Mutant(TT) 3 15 0 0 1.87 >0.05**
Wild type (CC) 7 35 14 70 2.3 <0.05*
* Signiﬁcant difference.
** Non-signiﬁcant difference.
Table 3 Segregation and frequency of T-allele versus C-allele
in the Genotypes of Autistic and Control groups.
Group C-allele T-allele
No. Frequency No. Frequency
Autistic 24 0.6 16 0.4
Control 34 0.85 6 0.3
P< 0.01(HS).
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social reciprocity and in language skills that are associated
with repetitive behaviors and restricted interests [16].
In our study, 80% of autistic children were diagnosed
before the age of 3 years. This is in agreement with Gray
and Tonge [17] who found that parents become concerned
about autistic behavior at the age of 12–30 months of age,
however, there is often a wide variation in the age at which
autistic children present for diagnosis to a specialized
developmental center [18].In our study 65% of patients were males and 35% were
females. McKusick [19] found that autism affects males more
than females and occurring at a ratio of 4:1. Also Shu et al.
[20], Allsopp et al. [21] and Newschaffer et al. [22] reported
that autism is more than twice as common in boys as in girls,
and this ratio increases to 5:1 at the high-ability end of the aut-
ism spectrum. This may indicate that males are predominantly
affected with autism than females.
In the present study, 80% of parents of patients are non
consanguineous compared to 85% in the control group. This
is in agreement with El-Baz et al. [23] who reported that the
rate of consanguinity is lower among parents of patients with
autism than in normal controls which means that consanguin-
ity has no role in autism. Similar ﬁndings were reported by
many authors [24-26].
In our study, family history of autism was present in 10%
among patients compared to 0% in the control group.
Families of individuals with autism tend to demonstrate a set
of cognitive disorders that are not seen in other family groups
[27]. A family history of autism was reported in 16% of autistic
patients versus 1% among the control [23].
Table 4 Correlation between C667T polymorphic genotypes with CARS and IQ.
IQ and CARS
C677T
CT genotype (mean ± SD) TT genotype (mean ± SD) CC genotype (mean ± SD) P-value
(i) I Q
1- Normal IQ 1 (5%) 0 (0%) 1 (5%)
2-Mild MR 4 (20%) 3 (15%) 3 (15%)
3-Moderate MR 4 (20%) 0 (0%) 2 (15%)
4-Severe MR 1 (5%) 0 (0%) 1 (5%)
IQ (mean ± SD) * a 50.8 ± 13.67 58.66 ± 5.5 57 ± 18.94 >0.05***
(ii) CARS** c
1-Moderate(=6) 4 (66.7%) 1 (16.6%) 1 (16.6%) >0.05***
2-Severe (=14) 6 (42.8%) 2 (14.2%) 6 (42.8%) >0.05***
(Mean ± SD)* b 36.3 ± 5.01 37.3 ± 4.61 37.1 ± 3.98 >0.05***
* Anova F test: a = 0.502, b = 0.096.
** Chi-square: 1.2, I.Q. mean of whole group, MR=mental retardation.
*** Non-signiﬁcant difference.
Table 5 Mean age for developmental milestones among different genotypes in the study.
Milestone Heterozygous CT (mean ± SD) Mutant TT (mean ± SD) Normal CC (mean ± SD) F (anova test) P-value
Gestational age (month) 38 ± 1.3 39 ± 0.00 39.1 ± 1.4 0.069 >0.05*
Birth weight (kg) 2.65 ± 0.44 2.63 ± 0.057 2.72 ± 0.423 0.094 >0.05*
Age of sitting (month) 8.5 ± 1.26 8.33 ± 0.57 8.57 ± 1.13 0.044 >0.05*
* Non-signiﬁcant difference.
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signiﬁcantly delayed among autistic children compared to the
control group. About 96% of autistic children had motor
developmental delay. Qualitative impairment in social interac-
tion and communication was also more commonly observed
than restricted interests and activities [28]. Children with aut-
ism may be delayed in acquiring motor activity, such as bicycle
riding. They may be poorly coordinated or have an abnormal
gait or posture and poor hand writing [29]. Some of the noted
behaviors in autism include delayed speech and language skills,
and not to point or wave ‘‘bye-bye’’ [30].
In this study, history of low birth weight was found to be
highly signiﬁcant among autistic children than controls. Kolev-
zon et al. [31] suggested the presence of non heritable prenatal
and perinatal risk factors for autism. An association is sug-
gested between autism and obstetric complications, prenatal
or intrapartum use of medications [32]. A signiﬁcantly higher
incidence of low birth weight and using instrumental tools dur-
ing delivery was reported among cases with autism than con-
trols [23]. Perinatal risk factors such as breech presentation,
low Apgar score, low birth weight (2500 g), gestational age at
birth of less than 35–37 weeks, and being small for gestational
age were associated with a statistically signiﬁcant increased risk
of autism [33]. In 2007, a review of risk factors demonstrated
associated obstetric conditions that included low birth weight,
gestation duration and hypoxia during childbirth with autism.
Studies focusing on single perinatal risk factor have reported a
positive association for low birth weight (<2500 g), and gesta-
tional age at birth of less than 37 weeks [34].
In our study, 90% of autistic patients presented with mild
to severe mental retardation and 10% with normal mentality.
According to CARS, severe cases were 14 (70%), moderate
cases were six (30%), while no mild cases were found. Autisticchildren have spectrum of IQ ranging from 0 to 60 [35]. It is
clear that autism is a biological brain disorder [15]. Genetic
factors are the most signiﬁcant causes for Autism Spectrum
Disorders [36]. Early studies of twins estimated heritability
to be over 90% [37]. Many of the non-autistic twins had learn-
ing or social disabilities [38].
In the present study the homozygote mutant 677TT geno-
type was present in 15% of the autistic children while the het-
erozygous 677CT genotype occurred in 50% of the autistic
children group. This was statistically highly signiﬁcant as
compared to the control group (<0.01). The T allele
frequency was 0.8 in autistic patients compared to an allele
frequency of 0.3 among the control group (<0.01). The
677T allele leads to valine substitution at amino acid 222
encoding a thermo labile enzyme with reduced activity in
folate metabolism. About ten percent of the North American
Population is T-homozygous for this polymorphism. There is
an ethnic variability in the frequency of the T allele. The
frequency in Mediterranean/Hispanics is greater than the
frequency in Caucasians which, in turn, is greater than in
Africans/African-Americans [39].
Our results are in agreement with Boris et al. [11] who
reported that homozygous 677TT genotype was present in
23% of the ASD children and the heterozygous 677CT geno-
type in 56% of children in the ASD group. The 677CT poly-
morphisms, whether homozygous or heterozygous, are
signiﬁcantly associated with ASD. The homozygous (TT) indi-
viduals are reported to have an approximately 50% decrease in
MTHFR thermo labile enzyme activity, and the heterozygous
(CT) a 30% decrease in enzyme activity as measured in their
lymphocytes. The homozygosity of 677T allele of the MTHFR
gene is more prevalent in the typical autism group [11,40,41].
MTHFR C677T polymorphism contributes to increased
340 R.M. Shawky et al.ASD risk, and periconceptional folic acid may reduce ASD
risk in those with MTHFR 677C>T polymorphism [42].
To conclude, although the 677CT variant alleles signiﬁ-
cantly increased in patients with autism, it is unlikely that this
association alone is sufﬁcient to produce the complex array of
symptoms associated with autism. Therefore, a search for
additional genomic, metabolic, epigenetic and environmental
risk factors should be undertaken.
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